Pioglitazone Use and Risk of Bladder Cancer

JAMA. 2015 Dec 15;314(23):2567-8. doi: 10.1001/jama.2015.13912.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Male
  • Pancreatic Neoplasms / chemically induced*
  • Prostatic Neoplasms / chemically induced*
  • Thiazolidinediones / adverse effects*
  • Urinary Bladder Neoplasms / chemically induced*

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones